FDA issued a Warning Letter to Tris Pharma Inc. on 3/26/2018 for a later inspection.
483 Tris Pharma Oct 2014

483 Tris Pharma Oct 2014

Paul Bellamy FDA$119.00 - Available Now

FDA investigators audited the Tris Pharma - Monmouth Junction, NJ, United States facility and issued inspectional observations (via FDA 483) on 01 Oct 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Oct 2014
  • Location: Monmouth Junction, United States
  • FEI: 3004712471
Add To Cart